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In a recent issue of Critical Care, 0.5 M sodium lactate
infusion for 24 hours was reported to increase cardiac
output in patients with acute heart failure. This effect
was associated with a concomitant metabolic alkalosis
and a negative water balance. Growing data strongly
support the role of lactate as a preferential oxidizable
substrate to supply energy metabolism leading to
improved organ function (heart and brain especially)
in ischemic conditions. Due to its sodium/chloride
imbalance, this solution prevents hyperchloremic
acidosis and limits fluid overload despite the
obligatory high sodium load. Sodium lactate solution
therefore shows many advantages and appears a very
promising means for resuscitation of critically ill
patients. Further studies are needed to establish the
most appropriate dose and indications for sodium
lactate infusion in order to prevent the occurrence of
severe hypernatremia and metabolic alkalosis.lactate infusion was responsible for an improved myocar-In a recent issue of Critical Care, Nalos and colleagues
evaluated the effect of 0.5 M sodium lactate (SL) solution
on cardiac function in patients presenting acute heart
failure [1]. The key result was that 24-hour infusion of SL
resulted in increased cardiac output, whereas it did not
change in the control group receiving Ringer lactate. This
difference could be accounted for, in large part, by an
augmentation in stroke volume. Further, patients receiving
SL developed metabolic alkalosis, hypokalemia and
hypernatremia, while their water balance was strongly
negative. These findings highlight the complexity of the
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2014First, hyperlactatemia is a good marker of poor outcome
in critically ill patients. Tissue hypoxia is responsible for
an increased lactate production resulting from glycolysis
[2,3]. Proponents of intensive intervention therefore
strongly believed that lactate was, to say the least, a useless
waste end product, if not a toxic one. However, the cause–
effect relationship is not clearly demonstrated. Indeed,
growing data support the notion that lactate production is
not deleterious, but rather is an adaptative response allow-
ing one to maintain an appropriate energetic metabolism
in the case of shock or organ failure [2-4]. Nevertheless,
the effect of solutions containing high lactate concentra-
tion in these situations is still a matter of debate.
Evidence is now accumulating that lactate is a preferred
substrate readily oxidizable in energy crisis conditions
[4-6]. In physiological basal situations, the myocardium
functions using energy from beta-oxidation of fatty acids.
When oxygen availability is limited, myocardial energy
metabolism switches from lipid oxidation to carbohydrate
oxidation [7]. Previous studies have already shown that
dial function in patients with septic shock or after cardiac
surgery [4,8,9]. The current study reproduces these results
in patients with acute heart failure [1]. Levy and colleagues
demonstrated that lactate deprivation worsened myocar-
dial metabolism and performance in rats with septic shock
[4]. This effect is believed to be due to, for the greater part,
the preferential lactate metabolism supplying sufficient
energy to the myocardium. However, this hypothesis
should be confirmed using direct measurements of lactate
oxidation in the heart. Similar results have been reported
in normal and injured brain, and confirmed the role of
lactate as an important source of energy [6,10,11]. Allaman
and colleagues described the essential impact of lactate
metabolism in the astrocyte–neuron coupling function
[12]. In traumatic brain injury, SL infusion was more effi-
cient than mannitol to decrease raised intracranial pressure
[11]. In a later study, a systematic SL infusion over 48 hoursd. The licensee has exclusive rights to distribute this article, in any medium, for
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The second point raised by Nalos and colleagues is the
induction of metabolic alkalosis by SL infusion [1],
which reflects the probable lactate oxidation. According
to the Stewart concept, the exogenous lactate enters into
the cells (metabolized anion) while exogenous sodium
remains in the plasma (nonmetabolized cation). These
modifications in turn induce an increase in the strong
ion difference and in the plasma bicarbonate concentra-
tion [14]. In agreement with other studies, SL infusion
induced metabolic alkalosis and hypokalemia and pre-
vented hyperchloremic acidosis. The authors emphasized
that metabolic alkalosis could improve cardiac function
[1]. However, it is known that metabolic alkalosis de-
creases coronary artery blood flow and worsens cardiac
arrhythmias, hypokalemia and cardiac contractility. On
the other hand, prevention of hyperchloremic acidosis
by the balanced SL solution could lead to an improve-
ment in organ function [15,16]. The global consequences
of such multiple and intricate metabolic modifications
on cardiac function remain questioned.
Third, the infusion of a large amount of sodium in
patients with acute heart failure represents a clear danger
as sodium restriction is the classic treatment for this condi-
tion. Surprisingly, the authors showed that the 24-hour and
48-hour water balances were strongly negative in patients
receiving SL compared with the control group. This finding
is in agreement with previous studies performed in cardiac
surgery and traumatic brain-injured patients [9,11]. The
mechanism by which SL influences water balance is not
clear. A lower required volume of infusion and/or a higher
urine output have been previously reported as a conse-
quence of the sodium/chloride imbalance of this solution
[9,11]. Unfortunately, these data are lacking in the study by
Nalos and colleagues. Independently of the underlying
mechanism, the resulting effect provides a substantial ad-
vantage in favor of SL infusion because fluid overload is as-
sociated with an increased morbi-mortality in various
critical conditions, especially cardiac failure [17].
In conclusion, the study by Nalos and colleagues pro-
vides additional arguments to strongly consider SL as a
valuable means for resuscitation. Thanks to its high lactate
and low chloride concentrations, SL offers substantial clin-
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